DUBLIN--(BUSINESS WIRE)--The "Interventional Cardiology: Implantable Pacemaker Products" report has been added to ResearchAndMarkets.com's offering. The global market for implantable pacemaker ...
The increasing incidence of cardiovascular disorders is a major catalyst driving the Implantable Heart Pacemaker Market. As conditions such as arrhythmia, bradycardia, and heart block become more ...
The global pacemakers market, valued at USD 4.4 billion in 2020, is anticipated to grow to USD 5.4 billion by 2027, at a CAGR of 3.0% during the forecast period (2021-2027). This growth is primarily ...
Boston Scientific has begun a clinical trial of its first modular cardiac rhythm implant system. It consists of a leadless pacemaker and an implantable cardioverter defibrillator—two separate devices ...
Dublin, Oct. 09, 2019 (GLOBE NEWSWIRE) -- The "Interventional Cardiology: Implantable Pacemaker Products" report has been added to ResearchAndMarkets.com's offering. The global market for implantable ...
A new FDA draft guidance has recommended that class III implantable pacemaker pulse generators be required to submit premarket approval applications or submit notice of completion of product ...
Correction: The original version of this story misstated CardioMessenger's FDA status. It is 510(k) cleared. Lake Oswego, Oregon-based Biotronik USA, the United States arm of Berlin-based medical ...
DUBLIN--(BUSINESS WIRE)--The "Interventional Cardiology: Implantable Pacemaker Products" report has been added to ResearchAndMarkets.com's offering. Global product sales are projected to expand at a ...
A magnet in the new iPhone 12 can potentially disrupt the function of some implantable medical equipment, according to recent findings from a Michigan hospital system. Last month, cardiologists from ...
Pacemaker implantation is a procedure that helps regulate irregular heart rhythms. The common conditions leading to the procedure in women differ from those in men. Following pacemaker implantation, ...
Children's Hospital Los Angeles cardiologist Michael Silka, MD, helped to pioneer the development of indications for the use of pacemakers and implantable defibrillators in young patients. From 1998 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback